Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

TEDDY--The Environmental Determinants of Diabetes in the Young: an observational clinical trial.

Hagopian WA, Lernmark A, Rewers MJ, Simell OG, She JX, Ziegler AG, Krischer JP, Akolkar B.

Ann N Y Acad Sci. 2006 Oct;1079:320-6.

PMID:
17130573
2.

Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study.

Uusitalo U, Liu X, Yang J, Aronsson CA, Hummel S, Butterworth M, Lernmark Å, Rewers M, Hagopian W, She JX, Simell O, Toppari J, Ziegler AG, Akolkar B, Krischer J, Norris JM, Virtanen SM; TEDDY Study Group.

JAMA Pediatr. 2016 Jan;170(1):20-8. doi: 10.1001/jamapediatrics.2015.2757.

3.

The Environmental Determinants of Diabetes in the Young (TEDDY) Study.

TEDDY Study Group.

Ann N Y Acad Sci. 2008 Dec;1150:1-13. doi: 10.1196/annals.1447.062.

4.

The environment and the origins of islet autoimmunity and Type 1 diabetes.

Eringsmark Regnéll S, Lernmark A.

Diabet Med. 2013 Feb;30(2):155-60. doi: 10.1111/dme.12099. Review.

5.

Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.

Redondo MJ, Babu S, Zeidler A, Orban T, Yu L, Greenbaum C, Palmer JP, Cuthbertson D, Eisenbarth GS, Krischer JP, Schatz D; Diabetes Prevention Trial Type 1 Study Group.

J Clin Endocrinol Metab. 2006 May;91(5):1705-13. Epub 2006 Feb 7.

PMID:
16464953
6.

The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design.

TEDDY Study Group.

Pediatr Diabetes. 2007 Oct;8(5):286-98.

PMID:
17850472
7.

The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.

Hagopian WA, Erlich H, Lernmark A, Rewers M, Ziegler AG, Simell O, Akolkar B, Vogt R Jr, Blair A, Ilonen J, Krischer J, She J; TEDDY Study Group.

Pediatr Diabetes. 2011 Dec;12(8):733-43. doi: 10.1111/j.1399-5448.2011.00774.x. Epub 2011 May 12.

8.

Timing of initial cereal exposure in infancy and risk of islet autoimmunity.

Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, Rewers M.

JAMA. 2003 Oct 1;290(13):1713-20.

PMID:
14519705
9.

Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.

Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E.

JAMA. 2003 Oct 1;290(13):1721-8.

PMID:
14519706
11.

Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up.

Elding Larsson H, Vehik K, Bell R, Dabelea D, Dolan L, Pihoker C, Knip M, Veijola R, Lindblad B, Samuelsson U, Holl R, Haller MJ; TEDDY Study Group; SEARCH Study Group; Swediabkids Study Group; DPV Study Group; Finnish Diabetes Registry Study Group.

Diabetes Care. 2011 Nov;34(11):2347-52. doi: 10.2337/dc11-1026. Epub 2011 Oct 4.

12.
13.

Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.

Törn C, Hadley D, Lee HS, Hagopian W, Lernmark Å, Simell O, Rewers M, Ziegler A, Schatz D, Akolkar B, Onengut-Gumuscu S, Chen WM, Toppari J, Mykkänen J, Ilonen J, Rich SS, She JX, Steck AK, Krischer J; TEDDY Study Group.

Diabetes. 2015 May;64(5):1818-29. doi: 10.2337/db14-1497. Epub 2014 Nov 24.

14.

Microbial exposure in infancy and subsequent appearance of type 1 diabetes mellitus-associated autoantibodies: a cohort study.

Virtanen SM, Takkinen HM, Nwaru BI, Kaila M, Ahonen S, Nevalainen J, Niinistö S, Siljander H, Simell O, Ilonen J, Hyöty H, Veijola R, Knip M.

JAMA Pediatr. 2014 Aug;168(8):755-63. doi: 10.1001/jamapediatrics.2014.296.

PMID:
24957949
15.

Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort.

Kupila A, Muona P, Simell T, Arvilommi P, Savolainen H, Hämäläinen AM, Korhonen S, Kimpimäki T, Sjöroos M, Ilonen J, Knip M, Simell O; Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland.

Diabetologia. 2001 Mar;44(3):290-7.

PMID:
11317658
16.

Autoimmune and clinical characteristics of type I diabetes in children with different genetic risk loads defined by HLA-DQB1 alleles. Childhood Diabetes in Finland Study Group.

Komulainen J, Knip M, Sabbah E, Vähäsalo P, Lounamaa R, Akerblom HK, Reijonen H, Ilonen J.

Clin Sci (Lond). 1998 Mar;94(3):263-9.

PMID:
9616260
17.

Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?

Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U.

Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):8-14.

PMID:
10707033
18.

Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.

Knip M, Kukko M, Kulmala P, Veijola R, Simell O, Akerblom HK, Ilonen J.

Am J Med Genet. 2002 May 30;115(1):48-54. Review.

PMID:
12116176
19.

Early determinants of type 1 diabetes: experience from the BABYDIAB and BABYDIET studies.

Hummel S, Ziegler AG.

Am J Clin Nutr. 2011 Dec;94(6 Suppl):1821S-1823S. doi: 10.3945/ajcn.110.000646. Epub 2011 Jun 1.

20.

Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.

Kukko M, Kimpimäki T, Kupila A, Korhonen S, Kulmala P, Savola K, Simell T, Keskinen P, Ilonen J, Simell O, Knip M.

Diabetologia. 2003 Jan;46(1):65-70. Epub 2002 Dec 18.

PMID:
12637984

Supplemental Content

Support Center